Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Total Debt (2022 - 2024)

Gossamer Bio's Total Debt history spans 3 years, with the latest figure at $9.6 million for Q1 2024.

  • For Q1 2024, Total Debt fell 53.97% year-over-year to $9.6 million; the TTM value through Mar 2024 reached $9.6 million, down 53.97%, while the annual FY2023 figure was $12.4 million, 47.35% down from the prior year.
  • Total Debt reached $9.6 million in Q1 2024 per GOSS's latest filing, down from $12.4 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $29.2 million in Q1 2022 to a low of $9.6 million in Q1 2024.
  • Average Total Debt over 3 years is $17.9 million, with a median of $17.6 million recorded in 2022.
  • Peak YoY movement for Total Debt: grew 2.78% in 2023, then plummeted 53.97% in 2024.
  • A 3-year view of Total Debt shows it stood at $23.6 million in 2022, then plummeted by 47.35% to $12.4 million in 2023, then dropped by 22.84% to $9.6 million in 2024.
  • Per Business Quant, the three most recent readings for GOSS's Total Debt are $9.6 million (Q1 2024), $12.4 million (Q4 2023), and $15.2 million (Q3 2023).